SP
SIH Partners Portfolio holdings
AUM
$1.05B
This Quarter Return
+0.17%
1 Year Return
+21.73%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.14B
AUM Growth
+$1.14B
(-20%)
Cap. Flow
-$258M
Cap. Flow
% of AUM
-22.66%
Top 10 Holdings %
Top 10 Hldgs %
64.91%
Holding
282
New
168
Increased
28
Reduced
29
Closed
25
Top Buys
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
$124M |
| 2 |
Stellantis
STLA
|
$33.7M |
| 3 |
KraneShares CSI China Internet ETF
KWEB
|
$33.3M |
| 4 |
NetEase
NTES
|
$28.6M |
| 5 |
iShares China Large-Cap ETF
FXI
|
$27.1M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$263M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$115M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$108M |
| 4 |
UBS Group
UBS
|
$92.8M |
| 5 |
Logitech
LOGI
|
$31.8M |
Sector Composition
| 1 | Consumer Discretionary | 37.33% |
| 2 | Financials | 13.28% |
| 3 | Healthcare | 13% |
| 4 | Communication Services | 4.43% |
| 5 | Materials | 4.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Ionis Pharmaceuticals
IONS
$9.1B
| $362K | 0.01% |
+11,999
| New | +$362K |
|
152
Axsome Therapeutics
AXSM
$6.14B
| $358K | 0.01% |
+3,071
| New | +$358K |
|
|
BPMC
153
DELISTED
Blueprint Medicines
BPMC
| $356K | 0.01% |
+4,027
| New | +$356K |
|
154
GE HealthCare
GEHC
$32.6B
| $345K | 0.01% |
+4,277
| New | +$345K |
|
155
ResMed
RMD
$39.7B
| $345K | 0.01% |
+1,542
| New | +$345K |
|
156
Foot Locker
FL
$2.3B
| $343K | 0.01% |
+24,319
| New | +$343K |
|
157
Agnico Eagle Mines
AEM
$74.1B
| $342K | 0.01% |
+3,158
| New | +$342K |
|
158
Alkermes
ALKS
$4.86B
| $338K | 0.01% |
+10,234
| New | +$338K |
|
159
CRISPR Therapeutics
CRSP
$4.78B
| $330K | 0.01% |
+9,712
| New | +$330K |
|
160
Krystal Biotech
KRYS
$4.24B
| $327K | 0.01% |
+1,815
| New | +$327K |
|
161
Cardinal Health
CAH
$35.7B
| $327K | 0.01% |
+2,370
| New | +$327K |
|
162
Twist Bioscience
TWST
$1.56B
| $326K | 0.01% |
+8,311
| New | +$326K |
|
163
EPAM Systems
EPAM
$9.71B
| $317K | 0.01% |
1,878
| – | – |
|
164
Adobe
ADBE
$146B
| $316K | 0.01% |
+823
| New | +$316K |
|
165
Humana
HUM
$37B
| $314K | 0.01% |
+1,187
| New | +$314K |
|
166
Scotiabank
BNS
$76.8B
| $312K | 0.01% |
+6,569
| New | +$312K |
|
167
Vaxcyte
PCVX
$4.09B
| $306K | 0.01% |
+8,109
| New | +$306K |
|
168
Centene
CNC
$14.5B
| $305K | 0.01% |
+5,016
| New | +$305K |
|
169
Globant
GLOB
$2.82B
| $303K | 0.01% |
2,574
| – | – |
|
|
VRNA
170
Verona Pharma
VRNA
$9.17B
| $302K | 0.01% |
+4,755
| New | +$302K |
|
171
Nuvalent
NUVL
$5.46B
| $296K | 0.01% |
+4,169
| New | +$296K |
|
172
ADMA Biologics
ADMA
$4.04B
| $296K | 0.01% |
+14,897
| New | +$296K |
|
|
SW
173
Smurfit Westrock plc
SW
$24.6B
| $294K | 0.01% |
+6,522
| New | +$294K |
|
174
Cytokinetics
CYTK
$5.94B
| $294K | 0.01% |
+7,307
| New | +$294K |
|
175
Bank of Montreal
BMO
$86.7B
| $287K | 0.01% |
+3,010
| New | +$287K |
|